Francesco Drago: Introducing an Innovative AI Approach For NSCLC Biomarkers Detection

Francesco Drago: Introducing an Innovative AI Approach For NSCLC Biomarkers Detection

Francesco Drago, Research Scientist at Ohio State University Cancer Center-James Cancer Hospital and Solove, shared a post on X:

“Proud to share our new paper led by Christian Rolfo, introducing an innovative AI approach for NSCLC biomarkers detection.

EGFR, ALK, BRAF and MET identified from routine H and E slides using CanvOI 1.1.”

Title: Validation of histopathology-based deep learning algorithms for detection of actionable non-small cell lung cancer biomarkers

Authors: Christian Rolfo, Efrat Ofek, Yoash Barak, Jonathan Weidenfeld, Razan Imad Haj, Yosef Molchanov, Alexander Loebel, David R. Braxton, John S. Cupp,
Rinat Yacobi, Chen Mayer, Francesco Drago, Camila Avivi, Nurit Paz-Yaacov, Assaf Avinoam, Jonathan Zalach, Addie Dvir, Inbal Gazy, Nir Peled, Damien Urban, Jair Bar, Dov Hershkoviz and Iris Barshack

Read the paper

Francesco Drago

Other articles on OncoDaily.